Edition:
India

Arrowhead Receives Regulatory Clearance To Begin Phase 1/2 Study Of Aro-Hbv For Treatment Of Hepatitis B


Thursday, 15 Feb 2018 

Feb 15 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD RECEIVES REGULATORY CLEARANCE TO BEGIN PHASE 1/2 STUDY OF ARO-HBV FOR TREATMENT OF HEPATITIS B. 

Company Quote

34.345
0.0 +0.00%
15 Oct 2019